Zhiyuan Pharmaceuticals Submits Hong Kong IPO Application on July 9

According to the Hong Kong Stock Exchange disclosure on July 9, Jiangsu Zhiyuan Pharmaceuticals Co., Ltd. submitted its main board listing application with CITIC Securities as the sole sponsor. The pharmaceutical company specializes in topical dermatology products and offers comprehensive skincare solutions spanning multiple therapeutic areas.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments